Patents by Inventor Barbara L. Schwartz

Barbara L. Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of amino-isoxazolidone compounds for improvement of implicit memory
    Publication number: 20040214873
    Abstract: A class of amino-isoxazolidone compounds is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Applicant: G. D. Searle & Co.
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • Use of amino-isoxazolidone compounds for improvement of lexical priming
    Patent number: 6656962
    Abstract: A class of amino-isoxazolidone compounds is described for use to improve lexical priming in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: December 2, 2003
    Assignee: Pharmacia Corporation
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • Use of amino-isoxazolidone compounds for facilitation of perceptual learning
    Publication number: 20020183372
    Abstract: A class of amino-isoxazolidone compounds is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Application
    Filed: May 22, 2002
    Publication date: December 5, 2002
    Applicant: G.D. Searle & Co.
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • Use of amino-isoxazolidone compounds for improvement of lexical priming
    Publication number: 20020183373
    Abstract: A class of amino-isoxazolidone compounds is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Application
    Filed: May 24, 2002
    Publication date: December 5, 2002
    Applicant: G.D. Searle & Co.
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • Use of amino-isoxazolidone compounds for improvement of implicit memory
    Patent number: 6420404
    Abstract: D-4-amino-3-isoxazolidone is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: July 16, 2002
    Assignee: G. D. Searle & Co.
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • Use of amino-isoxazolidone compounds for improvement of implicit memory
    Publication number: 20010027204
    Abstract: A class of amino-isoxazolidone compounds is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Application
    Filed: February 26, 2001
    Publication date: October 4, 2001
    Applicant: G.D. Searle & Co.
    Inventors: Robert L. Herting, Barbara L. Schwartz, Stephen I. Deutsch
  • System and method for screening for dementia
    Patent number: 5956125
    Abstract: An easily administered, non-invasive, sensitive and specific system and method for screening persons for dementia, particularly dementia of the Alzheimer's type, is provided. The system and method include means for irradiating the eye of a person with light, preferably light solely within the infrared spectrum, and means for generating a signal responsive to the amount of light reflected from the eye over a period of time. This signal is indicative of changes in the pupil's size over time. The system and method further include means for performing a Fourier transform upon this signal to provide a value indicative of the strength of this signal's frequency components. This value then is compared against a predetermined threshold value and, if this threshold value is exceeded, a higher probability is assigned to the person having dementia, particularly dementia of the Alzheimer's type.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: September 21, 1999
    Assignee: BioProbes, Inc.
    Inventors: Richard B. Rosse, Surendra K. Johri, Stephen I. Deutsch, Barbara L. Schwartz